Imprinting of insulin-like growth factor 2 is modulated during hematopoiesis.

Abstract:

:The transcription of insulin-like growth factor 2 (IGF-2) is affected by genomic imprinting, a multistep process through which the parental origin of a gene influences its transcription. The maternal copy of IGF-2 is silenced in most human tissues, but in the choroid plexus and the adult liver both alleles of IGF-2 are expressed. This study shows that though in peripheral blood mononuclear cells IGF-2 shows paternal allele-specific expression, in total bone marrow both alleles are transcribed. This modulation of imprinting is not attributable to use of the P1 promoter, because transcription from the P3 promoter occurred from both alleles. These results suggest that transcriptional recognition of the IGF-2 imprint can be modulated during hematopoiesis and may facilitate the development of in vitro model systems to study the transcriptional recognition of a genomic imprint.

journal_name

Blood

journal_title

Blood

authors

Morison IM,Eccles MR,Reeve AE

subject

Has Abstract

pub_date

2000-11-01 00:00:00

pages

3023-8

issue

9

eissn

0006-4971

issn

1528-0020

journal_volume

96

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs.

    abstract::Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene on the X-chromosome that result in skeletal and cardiac muscle damage and premature death. Studies in mice, including the mdx mouse model of DMD, have demonstrated that circulating bone marrow-derived cells can participate in skeletal musc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-06-2247

    authors: Dell'Agnola C,Wang Z,Storb R,Tapscott SJ,Kuhr CS,Hauschka SD,Lee RS,Sale GE,Zellmer E,Gisburne S,Bogan J,Kornegay JN,Cooper BJ,Gooley TA,Little MT

    更新日期:2004-12-15 00:00:00

  • Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells.

    abstract::Polycythemia vera (PV) treatment with interferon α (IFNα) is frequently limited by dose-related toxicity. PV CD34(+) cells are characterized by overexpression of Bcl-xL, which can be antagonized by ABT-737 leading to apoptosis. We explored the effects of ABT-737 and IFNα on PV hematopoiesis. Both IFNα and ABT-737 alon...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-279125

    authors: Lu M,Wang J,Li Y,Berenzon D,Wang X,Mascarenhas J,Xu M,Hoffman R

    更新日期:2010-11-18 00:00:00

  • Structural and functional characterization of a specific antidote for ticagrelor.

    abstract::Ticagrelor is a direct-acting reversibly binding P2Y12 antagonist and is widely used as an antiplatelet therapy for the prevention of cardiovascular events in acute coronary syndrome patients. However, antiplatelet therapy can be associated with an increased risk of bleeding. Here, we present data on the identificatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-622928

    authors: Buchanan A,Newton P,Pehrsson S,Inghardt T,Antonsson T,Svensson P,Sjögren T,Öster L,Janefeldt A,Sandinge AS,Keyes F,Austin M,Spooner J,Gennemark P,Penney M,Howells G,Vaughan T,Nylander S

    更新日期:2015-05-28 00:00:00

  • Pim2 cooperates with PML-RARalpha to induce acute myeloid leukemia in a bone marrow transplantation model.

    abstract::Although the potential role of Pim2 as a cooperative oncogene has been well described in lymphoma, its role in leukemia has remained largely unexplored. Here we show that high expression of Pim2 is observed in patients with acute promyelocytic leukemia (APL). To further characterize the cooperative role of Pim2 with p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-210070

    authors: Agrawal-Singh S,Koschmieder S,Gelsing S,Stocking C,Stehling M,Thiede C,Thoennissen NH,Köhler G,Valk PJ,Delwel R,Mills K,Bäumer N,Tickenbrock L,Hansen K,Berdel WE,Müller-Tidow C,Serve H

    更新日期:2010-06-03 00:00:00

  • Myeloma bone disease and proteasome inhibition therapies.

    abstract::Bone disease is one of the most debilitating manifestations of multiple myeloma. A complex interdependence exists between myeloma bone disease and tumor growth, creating a vicious circle of extensive bone destruction and myeloma progression. Proteasome inhibitors have recently been shown to promote bone formation in v...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2007-03-067710

    authors: Terpos E,Sezer O,Croucher P,Dimopoulos MA

    更新日期:2007-08-15 00:00:00

  • Proteolytic antibodies activate factor IX in patients with acquired hemophilia.

    abstract::Acquired hemophilia is a rare bleeding disorder characterized by the spontaneous occurrence of inhibitory antibodies against endogenous factor VIII (FVIII). IgG from some patients with acquired hemophilia hydrolyze FVIII. Because of the complex etiology of the disease, no clinical parameter, including the presence of ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2010-07-296103

    authors: Wootla B,Christophe OD,Mahendra A,Dimitrov JD,Repessé Y,Ollivier V,Friboulet A,Borel-Derlon A,Levesque H,Borg JY,Andre S,Bayry J,Calvez T,Kaveri SV,Lacroix-Desmazes S

    更新日期:2011-02-17 00:00:00

  • The differentiation program of embryonic definitive hematopoietic stem cells is largely alpha4 integrin independent.

    abstract::Previous analyses of the roles of alpha4 integrins in hematopoiesis by other groups have led to conflicting evidence. alpha4 integrin mutant cells developing in [alpha4 integrin(-/-): wt] chimeric mice are not capable of completing lymphomyeloid differentiation, whereas conditional inactivation of alpha4 integrin in a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4209

    authors: Gribi R,Hook L,Ure J,Medvinsky A

    更新日期:2006-07-15 00:00:00

  • Bispecific antibody-mediated immunotherapy of the BCL1 lymphoma: increased efficacy with multiple injections and CD28-induced costimulation.

    abstract::The BCL1 lymphoma in Balb/c mice can be successfully treated with bispecific (anti-CD3 x anti-idiotype) antibodies (BSABs). In these experiments, animals were injected intraperitoneally (IP) with 5 x 10(3) tumor cells (day 0) and treated with one single intravenous (IV) injection of 5 micrograms BSAB (day 9). Because ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Demanet C,Brissinck J,De Jonge J,Thielemans K

    更新日期:1996-05-15 00:00:00

  • Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor-beta 1 and independent accessory cell-derived contact and soluble factors.

    abstract::Natural killer cells (NK) were studied to determine factors important in their expansion. Flourescence-activated cell sorter (FACS) purified CD56+/CD3- NK cells cultured alone for 18 days in rIL-2 containing medium (1,000 U/mL) showed enhanced cytotoxicity but only minimal expansion. NK expansion was increased (12.5 +...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pierson BA,Gupta K,Hu WS,Miller JS

    更新日期:1996-01-01 00:00:00

  • The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis.

    abstract::Myofibroblasts are fibrosis-driving cells and are well characterized in solid organ fibrosis, but their role and cellular origin in bone marrow fibrosis remains obscure. Recent work has demonstrated that Gli1+ and LepR+ mesenchymal stromal cells (MSCs) are progenitors of fibrosis-causing myofibroblasts in the bone mar...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-02-834820

    authors: Kramann R,Schneider RK

    更新日期:2018-05-10 00:00:00

  • Dangerous small B-cell clones.

    abstract::The detection of a monoclonal immunoglobulin in serum or urine usually raises concerns about the size of the underlying B-cell-derived clone and possible systemic effects caused by its expansion. However, a small clone can synthesize a very toxic protein, producing devastating systemic damage and protean clinical pres...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2006-03-001164

    authors: Merlini G,Stone MJ

    更新日期:2006-10-15 00:00:00

  • High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver.

    abstract::Beginning in 1985, patients in British Columbia with Hodgkin lymphoma (HL) that was not controlled by conventional chemotherapy routinely underwent high-dose chemotherapy and autologous stem cell transplantation (HD-ASCT). Long-term complications of HD-ASCT have become apparent as more patients survive without recurre...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4689

    authors: Lavoie JC,Connors JM,Phillips GL,Reece DE,Barnett MJ,Forrest DL,Gascoyne RD,Hogge DE,Nantel SH,Shepherd JD,Smith CA,Song KW,Sutherland HJ,Toze CL,Voss NJ,Nevill TJ

    更新日期:2005-08-15 00:00:00

  • Characterization of the mouse von Willebrand factor promoter.

    abstract::Expression of the von Willebrand factor (vWF) gene is restricted to the endothelial and megakaryocyte lineages. Within the endothelium, expression of vWF varies between different vascular beds. We have previously shown that the human vWF promoter spanning a region between -2182 (relative to the start site of transcrip...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guan J,Guillot PV,Aird WC

    更新日期:1999-11-15 00:00:00

  • Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor.

    abstract::The malignant Reed-Sternberg cell of Hodgkin disease is an aberrant B cell that persists in an immunolgically mediated inflammatory infiltrate. Despite its nonproductive immunoglobulin genes, the Reed-Sternberg cell avoids the usual apoptotic fate of defective immune cells through an unknown mechanism. A likely candid...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Annunziata CM,Safiran YJ,Irving SG,Kasid UN,Cossman J

    更新日期:2000-10-15 00:00:00

  • Divergent effects of interleukin-4 (IL-4) on the granulocyte colony-stimulating factor and IL-3-supported myeloid colony formation from normal and leukemic bone marrow cells.

    abstract::Human recombinant interleukin-4 (IL-4) was studied for its effects on myeloid progenitor cells from normal and leukemic bone marrow cells in the presence and absence of additional growth factors. IL-4 itself did not support myeloid cluster or colony formation (CFU-GM). However, cultures supplied with IL-4 (300 U/mL) a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Vellenga E,de Wolf JT,Beentjes JA,Esselink MT,Smit JW,Halie MR

    更新日期:1990-02-01 00:00:00

  • Intragenic Factor IX restriction site polymorphism in hemophilia B variants.

    abstract::This study includes 47 normal subjects and 25 hemophilia B patients without inhibitor(s), showing different factor IX coagulant activity and antigen levels. Genomic DNA, digested with various restriction endonucleases, was hybridized with two different factor IX probes, ie, the cDNA and the subgenomic probe for the in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hassan HJ,Orlando M,Leonardi A,Chelucci C,Guerriero R,Mannucci PM,Mariani G,Peschle C

    更新日期:1985-02-01 00:00:00

  • How I treat hypereosinophilic syndromes.

    abstract::Hypereosinophilic syndromes (HESs) are a heterogeneous group of uncommon disorders characterized by marked peripheral eosinophilia and end organ manifestations attributable to the eosinophilia or unexplained in the clinical setting. Whereas corticosteroids remain the mainstay of treatment for most patients, recent dia...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2009-07-143552

    authors: Klion AD

    更新日期:2009-10-29 00:00:00

  • Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes.

    abstract::The U-A10 cell line, a doxorubicin-selected variant of human U-937 myeloid leukemia cells, exhibits a redistribution of anthracyclines into a expanded vesicular compartment. The acidic nature of this compartment was confirmed by vital staining with a pH sensitive dye, LysoSensor yellow/blue DND-160. Identification of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hurwitz SJ,Terashima M,Mizunuma N,Slapak CA

    更新日期:1997-05-15 00:00:00

  • A human monoclonal autoantibody recognizes a neoantigen on glycoprotein IIIa expressed on stored and activated platelets.

    abstract::We prepared a heterohybrid cell line that secretes a human IgM monoclonal autoantibody that recognizes an antigen found on thrombin-activated or stored platelets. The surface expression of the epitope recognized by this autoantibody, 5E5, increases with time as platelets age in vitro, suggesting that it may represent ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nugent DJ,Kunicki TJ,Berglund C,Bernstein ID

    更新日期:1987-07-01 00:00:00

  • Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA).

    abstract::Twenty-four adults with ALL were treated with AMSA alone or in combination. Twenty-two were treated at time of relapse and two patients after failing primary induction therapy. All had been treated with anthracyclines prior to receiving AMSA. Of the 22 patients with ALL in relapse, 4 achieved a complete remission. Two...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Arlin ZA,Fanucchi MP,Gee TS,Kempin SJ,Mertelsmann R,Young CW,Clarkson BD

    更新日期:1982-11-01 00:00:00

  • Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells.

    abstract::Interferon (IFN)-alpha inhibits DNA synthesis stimulated by low molecular weight B-cell growth factor (BCGF) in hairy cells in vitro, suggesting that the therapeutic efficacy of IFN-alpha in hairy cell leukemia (HCL) involves growth inhibition of malignant B cells. Evidence that the 16-Kd cell surface protein Leu-13 m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Evans SS,Lee DB,Han T,Tomasi TB,Evans RL

    更新日期:1990-12-15 00:00:00

  • Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts.

    abstract::Hematopoietic growth factors (HGFs) interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) individually have been shown to increase the percentage of acute myeloid leukemia (AML) blasts in S phase and enhance the cytotoxic effects of Ara-C against these blasts in culture. We compared in vit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bhalla K,Holladay C,Arlin Z,Grant S,Ibrado AM,Jasiok M

    更新日期:1991-11-15 00:00:00

  • Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.

    abstract::Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called "synthetic lethality" was applied, which relies on the addic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-05-501072

    authors: Cramer-Morales K,Nieborowska-Skorska M,Scheibner K,Padget M,Irvine DA,Sliwinski T,Haas K,Lee J,Geng H,Roy D,Slupianek A,Rassool FV,Wasik MA,Childers W,Copland M,Müschen M,Civin CI,Skorski T

    更新日期:2013-08-15 00:00:00

  • High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome.

    abstract::We treated 5 patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome and multifocal bone lesions or diffuse bone marrow plasmacytic infiltration with high-dose therapy (HDT) and autologous blood stem cell transplantation. In all cases, the treatment produced...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood.v99.8.3057

    authors: Jaccard A,Royer B,Bordessoule D,Brouet JC,Fermand JP

    更新日期:2002-04-15 00:00:00

  • Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1.

    abstract::Vascular cell adhesion molecule-1 (VCAM-1) and endothelial-leukocyte adhesion molecule-1 (ELAM-1) are adhesive proteins induced on endothelium by cytokines. We examined the contribution of these adhesive proteins to human peripheral blood monocyte adherence to endothelium using transfected Chinese hamster ovary (CHO) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Carlos T,Kovach N,Schwartz B,Rosa M,Newman B,Wayner E,Benjamin C,Osborn L,Lobb R,Harlan J

    更新日期:1991-05-15 00:00:00

  • Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo.

    abstract::Hepcidin controls systemic iron availability, and its excess contributes to the anemia of chronic diseases, the most prevalent anemia in hospitalized patients. We previously reported that heparins are efficient hepcidin inhibitors both in vitro and in vivo, but their anticoagulant activity limits therapeutic use. We s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-07-515221

    authors: Poli M,Asperti M,Naggi A,Campostrini N,Girelli D,Corbella M,Benzi M,Besson-Fournier C,Coppin H,Maccarinelli F,Finazzi D,Arosio P

    更新日期:2014-03-06 00:00:00

  • Extracellular ubiquitin inhibits the TNF-alpha response to endotoxin in peripheral blood mononuclear cells and regulates endotoxin hyporesponsiveness in critical illness.

    abstract::Ubiquitin is suggested to play a key role in essential intracellular functions, such as heat shock response, protein breakdown, and regulation of immune responses. Ubiquitin has also been detected in the extracellular space, but the function and biologic significance is unclear. We describe a new function of extracell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0918

    authors: Majetschak M,Krehmeier U,Bardenheuer M,Denz C,Quintel M,Voggenreiter G,Obertacke U

    更新日期:2003-03-01 00:00:00

  • Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells.

    abstract::Bortezomib (PS-341), a selective inhibitor of proteasomes, induces apoptosis in multiple myeloma (MM) cells; however, prolonged drug exposure may result in cumulative toxicity and the development of chemoresistance. Here we show that combining PK-11195 (PK), an antagonist to mitochondrial peripheral benzodiazepine rec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0547

    authors: Chauhan D,Li G,Podar K,Hideshima T,Mitsiades C,Schlossman R,Munshi N,Richardson P,Cotter FE,Anderson KC

    更新日期:2004-10-15 00:00:00

  • C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies.

    abstract::Cellular oncogenes have been localized at the breakpoints of characteristic chromosomal rearrangements occurring in certain hematologic malignancies. This has been reported to result in aberrant expression of the involved oncogenes. Over 90% of chronic myelogenous leukemia (CML) is characterized by a reciprocal transl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Romero P,Blick M,Talpaz M,Murphy E,Hester J,Gutterman J

    更新日期:1986-03-01 00:00:00

  • Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.

    abstract::Multicentric Castleman disease (MCD) is a lymphoproliferative disorder associated with human herpesvirus 8 (HHV-8) infection among persons with human immunodeficiency virus (HIV) infection. Treatment often includes chemotherapy, and progression to non-Hodgkin lymphoma frequently occurs. MCD is characterized in part by...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1721

    authors: Casper C,Nichols WG,Huang ML,Corey L,Wald A

    更新日期:2004-03-01 00:00:00